Ensayos clínicos de Migraña en Ohio
12 estudios sobre Migraña buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05156398A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1
Edades de 6 a 11 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Reclutando
Edades de 10 a 17 · Todos los sexos · Actualizado el 21 sept 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 16 sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- y 3 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT05987592A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 12 jun 2026 · NCT05164172Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
ReclutandoFase 4
Edades de 6 a 11 · Todos los sexos · Actualizado el 27 ene 2025 · NCT04748601Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 10 a 19 · Todos los sexos · Actualizado el 22 ago 2024 · NCT05752396De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.